[go: up one dir, main page]

SE9900025D0 - Method and composition for treatment of female sexual dysfunction - Google Patents

Method and composition for treatment of female sexual dysfunction

Info

Publication number
SE9900025D0
SE9900025D0 SE9900025A SE9900025A SE9900025D0 SE 9900025 D0 SE9900025 D0 SE 9900025D0 SE 9900025 A SE9900025 A SE 9900025A SE 9900025 A SE9900025 A SE 9900025A SE 9900025 D0 SE9900025 D0 SE 9900025D0
Authority
SE
Sweden
Prior art keywords
sexual dysfunction
female sexual
treatment
composition
agonists
Prior art date
Application number
SE9900025A
Other languages
English (en)
Inventor
John Stjernschaniz
Bahram Resul
Original Assignee
Synphora Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synphora Ab filed Critical Synphora Ab
Priority to SE9900025A priority Critical patent/SE9900025D0/sv
Publication of SE9900025D0 publication Critical patent/SE9900025D0/sv
Priority to AU21396/00A priority patent/AU762133B2/en
Priority to ES00901353T priority patent/ES2222172T3/es
Priority to US09/869,431 priority patent/US6562868B1/en
Priority to NZ512137A priority patent/NZ512137A/xx
Priority to PCT/SE2000/000006 priority patent/WO2000040248A1/en
Priority to EP00901353A priority patent/EP1140108B1/en
Priority to DE60011748T priority patent/DE60011748T2/de
Priority to JP2000592005A priority patent/JP2002534389A/ja
Priority to CA002353592A priority patent/CA2353592A1/en
Priority to AT00901353T priority patent/ATE269706T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE9900025A 1999-01-08 1999-01-08 Method and composition for treatment of female sexual dysfunction SE9900025D0 (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE9900025A SE9900025D0 (sv) 1999-01-08 1999-01-08 Method and composition for treatment of female sexual dysfunction
AT00901353T ATE269706T1 (de) 1999-01-08 2000-01-04 Methoden und zusammenstellungen zur behandlung der weiblichen sexuellen dysfunktion
NZ512137A NZ512137A (en) 1999-01-08 2000-01-04 Prostaglandin E2 (PGE2) and PGE4 analogues, which are antagonists of the EP2 receptor for treatment of female sexual dysfunction
ES00901353T ES2222172T3 (es) 1999-01-08 2000-01-04 Procedimiento y composicion para el tratamiento de la disfuncion sexual femenina.
US09/869,431 US6562868B1 (en) 1999-01-08 2000-01-04 Method for treatment of female sexual dysfunction
AU21396/00A AU762133B2 (en) 1999-01-08 2000-01-04 Method and composition for treatment of female sexual dysfunction
PCT/SE2000/000006 WO2000040248A1 (en) 1999-01-08 2000-01-04 Method and composition for treatment of female sexual dysfunction
EP00901353A EP1140108B1 (en) 1999-01-08 2000-01-04 Method and composition for treatment of female sexual dysfunction
DE60011748T DE60011748T2 (de) 1999-01-08 2000-01-04 Methoden und zusammenstellungen zur behandlung der weiblichen sexuellen dysfunktion
JP2000592005A JP2002534389A (ja) 1999-01-08 2000-01-04 女性性機能障害の治療のための方法および組成物
CA002353592A CA2353592A1 (en) 1999-01-08 2000-01-04 Method and composition for treatment of female sexual dysfunction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9900025A SE9900025D0 (sv) 1999-01-08 1999-01-08 Method and composition for treatment of female sexual dysfunction

Publications (1)

Publication Number Publication Date
SE9900025D0 true SE9900025D0 (sv) 1999-01-08

Family

ID=20414034

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9900025A SE9900025D0 (sv) 1999-01-08 1999-01-08 Method and composition for treatment of female sexual dysfunction

Country Status (11)

Country Link
US (1) US6562868B1 (sv)
EP (1) EP1140108B1 (sv)
JP (1) JP2002534389A (sv)
AT (1) ATE269706T1 (sv)
AU (1) AU762133B2 (sv)
CA (1) CA2353592A1 (sv)
DE (1) DE60011748T2 (sv)
ES (1) ES2222172T3 (sv)
NZ (1) NZ512137A (sv)
SE (1) SE9900025D0 (sv)
WO (1) WO2000040248A1 (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2812192B1 (fr) * 2000-07-28 2003-01-31 Oreal Utilisation d'antagonistes de recepteur des prostaglandines ep-3 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
GB0112699D0 (en) 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof
PT2465537T (pt) 2002-10-10 2016-08-03 Ono Pharmaceutical Co Microsferas compreendendo ono-1301
GB0329620D0 (en) * 2003-12-22 2004-01-28 Pharmagene Lab Ltd EP2 receptor agonists
EP1723132A1 (en) 2004-02-12 2006-11-22 Asterand Uk Limited Ep2 receptor agonists
GB0501192D0 (en) 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
AU2006277786B2 (en) 2005-08-09 2012-09-06 Asterand Uk Acquisition Limited EP2 receptor agonists
BRPI0709720A2 (pt) * 2006-04-04 2011-07-26 Allergan Inc compostos terapÊuticos
EP2220057A4 (en) * 2007-11-14 2011-10-12 Cayman Chem Co PROSTAGLANDIN E1 AND E2 ANALOGUES FOR THE TREATMENT OF VARIOUS MEDICAL CONDITIONS
CN101939288A (zh) * 2008-02-05 2011-01-05 阿斯特兰德英国有限公司 用于治疗高眼压的二氟联苯酰胺衍生物
JP6400479B2 (ja) 2012-10-29 2018-10-03 株式会社カルディオ 肺疾患特異的治療剤
WO2015056504A1 (ja) 2013-10-15 2015-04-23 小野薬品工業株式会社 薬剤溶出性ステントグラフト
CN103868768B (zh) * 2014-02-14 2016-03-09 河南省农业科学院植物保护研究所 一种昆虫触角及附肢的扫描电镜样品处理方法
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1488006A (en) * 1974-02-13 1977-10-05 Ono Pharmaceutical Co Prostaglandin analogues
LU72128A1 (sv) * 1974-03-26 1975-08-20
US4190670A (en) * 1974-03-26 1980-02-26 Gist Brocades N.V. Prostaglandin derivatives
US4164446A (en) * 1974-03-26 1979-08-14 Gist Brocades N.V. Prostaglandin derivatives
US5698598A (en) * 1995-08-04 1997-12-16 Allergan EP2 -receptor agonists as agents for lowering intraocular pressure
SE9702681D0 (sv) 1997-07-10 1997-07-10 Pharmacia & Upjohn Ab Method and composition for treatment of impotence
US20020004529A1 (en) * 1997-10-20 2002-01-10 Gary W. Neal Methods, compositions, and kits for enhancing female sexual desire and responsiveness
WO1999021562A1 (en) * 1997-10-28 1999-05-06 Asivi, Llc Treatment of female sexual dysfunction
US5877211A (en) * 1997-11-21 1999-03-02 Allergan EP2 receptor agonists as neuroprotective agents for the eye

Also Published As

Publication number Publication date
AU2139600A (en) 2000-07-24
CA2353592A1 (en) 2000-07-13
DE60011748D1 (de) 2004-07-29
EP1140108A1 (en) 2001-10-10
WO2000040248A1 (en) 2000-07-13
EP1140108B1 (en) 2004-06-23
US6562868B1 (en) 2003-05-13
ATE269706T1 (de) 2004-07-15
NZ512137A (en) 2002-12-20
ES2222172T3 (es) 2005-02-01
AU762133B2 (en) 2003-06-19
DE60011748T2 (de) 2005-07-28
JP2002534389A (ja) 2002-10-15

Similar Documents

Publication Publication Date Title
SE9900025D0 (sv) Method and composition for treatment of female sexual dysfunction
PT957914E (pt) Formulacao de agonistas de 5-ht
DK1317419T3 (da) Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler
ATE299740T1 (de) Kombination aus einem no-donor und einem antioxidans zur behanndlung sexueller störungen
PE20010924A1 (es) Compuestos inhibidores de fosfodiesterasa utiles para el tratamiento de la disfuncion sexual femenina
WO2003000343A3 (en) Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
TW200503756A (en) Dispersible formulation of an anti-inflammatory agent
EA200301200A1 (ru) Проникающая через кожу композиция селективного ингибитора циклооксигеназы-2
DK0996429T3 (da) Faste opløsninger og faste dispersioner i vand tungtopløselige lægemidler
EA200400966A1 (ru) Новые лекарственные формы замещенного бензимидазола и способ их применения
DK1239849T3 (da) Farmaceutiske formuleringer omfattende resveratrol og anvendelse deraf
SE9702681D0 (sv) Method and composition for treatment of impotence
IL158559A (en) Use of 5-lipoxygenase inhibitors for the preparation of a pharmaceutical composition for treating acne
WO1999021558A3 (en) Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
CA2383785A1 (en) Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
DK0969843T3 (da) Antitussive formuleringer indeholdende theobromin
DE69927582D1 (de) Neue analoga von 16-hydroxyeicosatetraensäure
AU2002215982A1 (en) Topical treatment of mastalgia with arometese inhibitors such as androstendione
WO2002100404A3 (en) Pyridoxal in combination with serotonin re-uptake inhibitor for the treatment of hot flushes
ATE395061T1 (de) Topische zusammensetzungen zur transdermalen gabe von niacin prodrugs sowie verfahren zur behandlung von hyperlipidämie
EP1051995A3 (en) 5HT1 receptor agonists and a cox-2 inhibitor or NSAID for the treatment of migraine
AU7393201A (en) Drug combination for the treatment of headache comprising a non-steroidal anti-inflammatory drug
PT1347753E (pt) Composicao topica e metodo para o tratamento da incontinencia urinaria de stress
WO2004056353A3 (en) Device and method for delivering mmp inhibitors
ECSP982720A (es) Formulacion que contiene un opioide en combinacion con un agonista adrenergico y su utilizacion como analgesico